Chapter/Section Purchase

1 Study Coverage
1.1 Inactivated Polio Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Inactivated Polio Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Government
1.2.3 Private Sector
1.3 Market by Application
1.3.1 Global Inactivated Polio Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pediatrics
1.3.3 Adults
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Inactivated Polio Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Inactivated Polio Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Inactivated Polio Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Inactivated Polio Vaccine Sales by Region
2.4.1 Global Inactivated Polio Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Inactivated Polio Vaccine by Region (2023-2028)
2.5 Global Inactivated Polio Vaccine Revenue by Region
2.5.1 Global Inactivated Polio Vaccine Revenue by Region (2017-2022)
2.5.2 Global Inactivated Polio Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Inactivated Polio Vaccine Sales by Manufacturers
3.1.1 Global Top Inactivated Polio Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Inactivated Polio Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Inactivated Polio Vaccine in 2021
3.2 Global Inactivated Polio Vaccine Revenue by Manufacturers
3.2.1 Global Inactivated Polio Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Inactivated Polio Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Inactivated Polio Vaccine Revenue in 2021
3.3 Global Inactivated Polio Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Inactivated Polio Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Inactivated Polio Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Inactivated Polio Vaccine Sales by Type
4.1.1 Global Inactivated Polio Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Inactivated Polio Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Inactivated Polio Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Inactivated Polio Vaccine Revenue by Type
4.2.1 Global Inactivated Polio Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Inactivated Polio Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Inactivated Polio Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Inactivated Polio Vaccine Price by Type
4.3.1 Global Inactivated Polio Vaccine Price by Type (2017-2022)
4.3.2 Global Inactivated Polio Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Inactivated Polio Vaccine Sales by Application
5.1.1 Global Inactivated Polio Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Inactivated Polio Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Inactivated Polio Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Inactivated Polio Vaccine Revenue by Application
5.2.1 Global Inactivated Polio Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Inactivated Polio Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Inactivated Polio Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Inactivated Polio Vaccine Price by Application
5.3.1 Global Inactivated Polio Vaccine Price by Application (2017-2022)
5.3.2 Global Inactivated Polio Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Inactivated Polio Vaccine Market Size by Type
6.1.1 North America Inactivated Polio Vaccine Sales by Type (2017-2028)
6.1.2 North America Inactivated Polio Vaccine Revenue by Type (2017-2028)
6.2 North America Inactivated Polio Vaccine Market Size by Application
6.2.1 North America Inactivated Polio Vaccine Sales by Application (2017-2028)
6.2.2 North America Inactivated Polio Vaccine Revenue by Application (2017-2028)
6.3 North America Inactivated Polio Vaccine Market Size by Country
6.3.1 North America Inactivated Polio Vaccine Sales by Country (2017-2028)
6.3.2 North America Inactivated Polio Vaccine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Inactivated Polio Vaccine Market Size by Type
7.1.1 Europe Inactivated Polio Vaccine Sales by Type (2017-2028)
7.1.2 Europe Inactivated Polio Vaccine Revenue by Type (2017-2028)
7.2 Europe Inactivated Polio Vaccine Market Size by Application
7.2.1 Europe Inactivated Polio Vaccine Sales by Application (2017-2028)
7.2.2 Europe Inactivated Polio Vaccine Revenue by Application (2017-2028)
7.3 Europe Inactivated Polio Vaccine Market Size by Country
7.3.1 Europe Inactivated Polio Vaccine Sales by Country (2017-2028)
7.3.2 Europe Inactivated Polio Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Inactivated Polio Vaccine Market Size by Type
8.1.1 Asia Pacific Inactivated Polio Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Inactivated Polio Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Inactivated Polio Vaccine Market Size by Application
8.2.1 Asia Pacific Inactivated Polio Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Inactivated Polio Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Inactivated Polio Vaccine Market Size by Region
8.3.1 Asia Pacific Inactivated Polio Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Inactivated Polio Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Inactivated Polio Vaccine Market Size by Type
9.1.1 Latin America Inactivated Polio Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Inactivated Polio Vaccine Revenue by Type (2017-2028)
9.2 Latin America Inactivated Polio Vaccine Market Size by Application
9.2.1 Latin America Inactivated Polio Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Inactivated Polio Vaccine Revenue by Application (2017-2028)
9.3 Latin America Inactivated Polio Vaccine Market Size by Country
9.3.1 Latin America Inactivated Polio Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Inactivated Polio Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Inactivated Polio Vaccine Market Size by Type
10.1.1 Middle East and Africa Inactivated Polio Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Inactivated Polio Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Inactivated Polio Vaccine Market Size by Application
10.2.1 Middle East and Africa Inactivated Polio Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Inactivated Polio Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Inactivated Polio Vaccine Market Size by Country
10.3.1 Middle East and Africa Inactivated Polio Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Inactivated Polio Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Inactivated Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sanofi Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Overview
11.2.3 GSK Inactivated Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 GSK Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GSK Recent Developments
11.3 Bibcol
11.3.1 Bibcol Corporation Information
11.3.2 Bibcol Overview
11.3.3 Bibcol Inactivated Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bibcol Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bibcol Recent Developments
11.4 Serum Institute
11.4.1 Serum Institute Corporation Information
11.4.2 Serum Institute Overview
11.4.3 Serum Institute Inactivated Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Serum Institute Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Serum Institute Recent Developments
11.5 Tiantan Biological
11.5.1 Tiantan Biological Corporation Information
11.5.2 Tiantan Biological Overview
11.5.3 Tiantan Biological Inactivated Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Tiantan Biological Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Tiantan Biological Recent Developments
11.6 Panacea Biotec
11.6.1 Panacea Biotec Corporation Information
11.6.2 Panacea Biotec Overview
11.6.3 Panacea Biotec Inactivated Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Panacea Biotec Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Panacea Biotec Recent Developments
11.7 Bio-Med
11.7.1 Bio-Med Corporation Information
11.7.2 Bio-Med Overview
11.7.3 Bio-Med Inactivated Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Bio-Med Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Bio-Med Recent Developments
11.8 Halfkin Bio-Pharmaceuticals
11.8.1 Halfkin Bio-Pharmaceuticals Corporation Information
11.8.2 Halfkin Bio-Pharmaceuticals Overview
11.8.3 Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Halfkin Bio-Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Inactivated Polio Vaccine Industry Chain Analysis
12.2 Inactivated Polio Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Inactivated Polio Vaccine Production Mode & Process
12.4 Inactivated Polio Vaccine Sales and Marketing
12.4.1 Inactivated Polio Vaccine Sales Channels
12.4.2 Inactivated Polio Vaccine Distributors
12.5 Inactivated Polio Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Inactivated Polio Vaccine Industry Trends
13.2 Inactivated Polio Vaccine Market Drivers
13.3 Inactivated Polio Vaccine Market Challenges
13.4 Inactivated Polio Vaccine Market Restraints
14 Key Findings in The Global Inactivated Polio Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer